185 related articles for article (PubMed ID: 21716133)
41. The prevalence of coeliac disease in Libyan children with type 1 diabetes mellitus.
Ashabani A; Abushofa U; Abusrewill S; Abdelazez M; Tucková L; Tlaskalová-Hogenová H
Diabetes Metab Res Rev; 2003; 19(1):69-75. PubMed ID: 12592646
[TBL] [Abstract][Full Text] [Related]
42. Omitting control biopsy in paediatric coeliac disease: a follow-up study.
Killander A; Arnell H; Hagenäs L; Finkel Y
Acta Paediatr; 2007 Aug; 96(8):1190-4. PubMed ID: 17578488
[TBL] [Abstract][Full Text] [Related]
43. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T
J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
[TBL] [Abstract][Full Text] [Related]
44. [Determination of anti-transglutaminase antibodies in the diagnosis of coeliac disease in children: results of a five year prospective study].
Laadhar L; Bouaziz N; Ben Ayed M; Chaabouni M; Boudawara T; Hachicha M; Jliri R; Triki A; Masmoudi H
Ann Biol Clin (Paris); 2004; 62(4):431-6. PubMed ID: 15297237
[TBL] [Abstract][Full Text] [Related]
45. Tissue transglutaminase antibody determination in celiac disease. Analysis of diagnostic specificity of anti-human IgA-type assays.
Földes-Papp Z; Demel U; Berry D; Domej W; Fuchs D; Tilz GP
J Immunoassay Immunochem; 2002; 23(2):211-27. PubMed ID: 12033644
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of coeliac disease in the adult population of central Greece.
Roka V; Potamianos SP; Kapsoritakis AN; Yiannaki EE; Koukoulis GN; Stefanidis I; Koukoulis GK; Germenis AE
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):982-7. PubMed ID: 18049168
[TBL] [Abstract][Full Text] [Related]
47. Antiendomysial and antitissue transglutaminase antibodies in gluten-induced enteropathy.
Tărmure S; Grigorescu M; Cristea A; Togănel E; Dumitra D
Rom J Gastroenterol; 2002 Jun; 11(2):91-5. PubMed ID: 12145663
[TBL] [Abstract][Full Text] [Related]
48. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG
Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411
[TBL] [Abstract][Full Text] [Related]
49. Childhood coeliac disease: towards an improved serological mass screening strategy.
Hogen Esch CE; Csizmadia GD; van Hoogstraten IM; Schreurs MW; Mearin ML; von Blomberg BM
Aliment Pharmacol Ther; 2010 Apr; 31(7):760-6. PubMed ID: 20047580
[TBL] [Abstract][Full Text] [Related]
50. How do Swedish paediatric clinics diagnose coeliac disease? Results of a nationwide questionnaire study.
Stenhammar L; Högberg L; Danielsson L; Ascher H; Dannaeus A; Hernell O; Ivarsson A; Lindberg E; Lindquist B; Nivenius K
Acta Paediatr; 2006 Nov; 95(11):1495-7. PubMed ID: 17062483
[TBL] [Abstract][Full Text] [Related]
51. Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?
Lo Iacono O; Petta S; Venezia G; Di Marco V; Tarantino G; Barbaria F; Mineo C; De Lisi S; Almasio PL; Craxì A
Am J Gastroenterol; 2005 Nov; 100(11):2472-7. PubMed ID: 16279902
[TBL] [Abstract][Full Text] [Related]
52. Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease.
Donaldson MR; Book LS; Leiferman KM; Zone JJ; Neuhausen SL
J Clin Gastroenterol; 2008 Mar; 42(3):256-60. PubMed ID: 18223500
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis of coeliac disease in children younger than 2 years.
Mišak Z; Hojsak I; Jadrešin O; Kekez AJ; Abdović S; Kolaček S
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):201-5. PubMed ID: 23325441
[TBL] [Abstract][Full Text] [Related]
54. IgA-antitissue transglutaminase: validation of a commercial assay for diagnosing coeliac disease.
West J; Lloyd CA; Hill PG; Holmes GK
Clin Lab; 2002; 48(5-6):241-6. PubMed ID: 12071574
[TBL] [Abstract][Full Text] [Related]
55. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis.
Volta U; Granito A; Parisi C; Fabbri A; Fiorini E; Piscaglia M; Tovoli F; Grasso V; Muratori P; Pappas G; De Giorgio R
J Clin Gastroenterol; 2010 Mar; 44(3):186-90. PubMed ID: 20042872
[TBL] [Abstract][Full Text] [Related]
56. Is gluten challenge really necessary for the diagnosis of coeliac disease in children younger than age 2 years?
Wolters VM; van de Nadort C; Gerritsen SA; Kneepkens CM; Ten Kate FJ; Gijsbers CF; Schweizer JJ; Nikkels PG; Benninga MA; Houwen RH
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):566-70. PubMed ID: 19367182
[TBL] [Abstract][Full Text] [Related]
57. Celiac Disease Management in the United Kingdom Specialist Pediatric Gastroenterology Centers-A Service Survey.
Paul SP; Balakumar V; Gillett PM
J Pediatr Gastroenterol Nutr; 2021 Jun; 72(6):e149-e153. PubMed ID: 33908736
[TBL] [Abstract][Full Text] [Related]
58. IgA class anti-endomysial and anti-tissue transglutaminase antibodies in relation to duodenal mucosa changes in coeliac disease.
Kotze LM; Utiyama SR; Nisihara RM; de Camargo VF; Ioshii SO
Pathology; 2003 Feb; 35(1):56-60. PubMed ID: 12701686
[TBL] [Abstract][Full Text] [Related]
59. Coeliac disease diagnosed at Starship Children's Hospital: 1999-2002.
Westerbeek E; Mouat S; Wesley A; Chin S
N Z Med J; 2005 Aug; 118(1220):U1613. PubMed ID: 16132074
[TBL] [Abstract][Full Text] [Related]
60. [Latent celiac disease in subjects with serum anti-endomysial antibodies and normal intestinal biopsy].
Piccoli A; Capelli P; Castagnini A; Cipolli M; Contreas G; Ulmi D; Zanoni G; Valletta E
Pediatr Med Chir; 2002; 24(5):358-62. PubMed ID: 12494536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
